Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study
BackgroundNo phase 3 studies have yet been conducted for patients with non–clear cell (CC) renal cell carcinoma (RCC) exclusively due to the rare occurrence of the disease and the heterogenicity in tumor morphology. Consequently, there is no evidence of the optimal treatment,...
Main Authors: | Ida Marie Lind Rasmussen, Anne Vest Soerensen, Anne Kirstine Møller, Gitte Fredberg Persson, Jesper Andreas Palshof, Gry Assam Taarnhøj, Helle Pappot |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-09-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2022/9/e36632 |
Similar Items
-
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
by: Gry A. Taarnhøj, et al.
Published: (2020-05-01) -
Patient-reported outcomes used actively in cancer patients undergoing antineoplastic treatment: A mini-review of the Danish landscape
by: Helle Pappot, et al.
Published: (2024-12-01) -
The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial
by: Gry Assam Taarnhøj, et al.
Published: (2023-10-01) -
Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature
by: G. A. Taarnhøj, et al.
Published: (2019-01-01) -
Detektif indigo /
by: Faisal Tehrani, 1974-
Published: (2005)